نتائج البحث - Natalie Filmann

  • يعرض 1 - 8 نتائج من 8
تنقيح النتائج
  1. 1
    Short and Long-Term Effectiveness of Ustekinumab in Patients with Crohn’s Disease: Real-World Data from a German IBD Cohort

    Short and Long-Term Effectiveness of Ustekinumab in Patients with Crohn’s Disease: Real-World Data from a German IBD Cohort حسب Alica Kubesch, L Rueter, Karima Farrag, Thomas Krause, K Stienecker, Johannes Hausmann, Natalie Filmann, Axel Dignaß, Jürgen M. Stein, Irina Blumenstein

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Interleukin-22 predicts severity and death in advanced liver cirrhosis: a prospective cohort study

    Interleukin-22 predicts severity and death in advanced liver cirrhosis: a prospective cohort study حسب Bernd Kronenberger, Ina Rudloff, Malte Bachmann, Friederike Brunner, Lisa Kapper, Natalie Filmann, Oliver Waidmann, Eva Herrmann, Josef Pfeilschifter, Stefan Zeuzem, Albrecht Piiper, Heiko Mühl

    منشور في 2012
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Ceramide synthase 2 deficiency aggravates AOM-DSS-induced colitis in mice: role of colon barrier integrity

    Ceramide synthase 2 deficiency aggravates AOM-DSS-induced colitis in mice: role of colon barrier integrity حسب Stephanie Oertel, Klaus Scholich, Andreas Weigert, Dominique Thomas, Julia Schmetzer, Sandra Trautmann, Marthe-Susanna Wegner, Heinfried H. Radeke, Natalie Filmann, Bernhard Brüne, Gerd Geißlinger, Irmgard Tegeder, Sabine Grösch

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Viral and Host Responses After Stopping Long-term Nucleos(t)ide Analogue Therapy in HBeAg-Negative Chronic Hepatitis B

    Viral and Host Responses After Stopping Long-term Nucleos(t)ide Analogue Therapy in HBeAg-Negative Chronic Hepatitis B حسب Christoph Höner zu Siederdissen, Franziska Rinker, Benjamin Maasoumy, Steffen B. Wiegand, Natalie Filmann, Christine S. Falk, Katja Deterding, Kerstin Port, Carola Mix, Michael P. Manns, Eva Herrmann, Heiner Wedemeyer, Anke Kraft, Markus Cornberg

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Prevalence of Anemia in Inflammatory Bowel Diseases in European Countries

    Prevalence of Anemia in Inflammatory Bowel Diseases in European Countries حسب Natalie Filmann, Julia Rey, Sven Schneeweiss, Sandro Ardizzone, Palle Bager, Gaetano Bergamaschi, Ioannis E. Κoutroubakis, Stefan Lindgren, Felipe de la Morena, Bjørn Moum, Stephan R. Vavricka, Oliver Schröder, Eva Herrmann, Irina Blumenstein

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Predictive value of a novel digital risk calculator to determine early patient outcomes after major surgery: a proof-of-concept pilot study

    Predictive value of a novel digital risk calculator to determine early patient outcomes after major surgery: a proof-of-concept pilot study حسب Svenja Sliwinski, Sara Fatima Faqar-Uz-Zaman, Jan Heil, Lisa Mohr, Charlotte Detemble, Julia Dreilich, Dora Zmuc, Wolf O. Bechstein, Sven Becker, Felix K.‐H. Chun, Wojciech Derwich, W Schreiner, Christine Solbach, Johannes Fleckenstein, Natalie Filmann, Andreas A. Schnitzbauer

    منشور في 2024
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Colonization with multidrug-resistant organisms is associated with in increased mortality in liver transplant candidates

    Colonization with multidrug-resistant organisms is associated with in increased mortality in liver transplant candidates حسب Philip G. Ferstl, Natalie Filmann, Eva-Maria Heilgenthal, Andreas A. Schnitzbauer, Wolf O. Bechstein, Volkhard A. J. Kempf, David Villinger, Tilman Schultze, Michael Hogardt, Christoph Stephan, Haitham Mutlak, Nina Weiler, Marcus M. Mücke, Jonel Trebicka, Stefan Zeuzem, Oliver Waidmann, Martin‐Walter Welker

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors

    mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors حسب Andreas A. Schnitzbauer, Natalie Filmann, René Adam, Philippe Bachellier, Wolf O. Bechstein, Thomas Becker, Sherrie Bhoori, Itxarone Bilbao, Jens Brockmann, Patrizia Burra, O. Chazoullières, Umberto Cillo, M. Colledan, C. Duvoux, Tom M. Ganten, Jean Gugenheim, Michael Heise, Bart van Hoek, Neville V. Jamieson, Koert P. de Jong, Christian Klein, Jürgen Klempnauer, Norman M. Kneteman, Jan Lerut, Heikki Mäkisalo, Vincenzo Mazzaferro, Darius F. Mirza, Silvio Nadalin, P. Neuhaus, G.-P. Pageaux, Antonio Daniele Pinna, Jaques Pirenne, Johann Pratschke, James Powel, Markus Rentsch, Magnus Rizell, G. Rossi, Lionel Rostaing, André Roy, Tim Scholz, Utz Settmacher, Thomas Soliman, Simone I. Strasser, Gunnar Söderdahl, Roberto Troisi, Víctor Sánchez Turrión, Hans J. Schlitt, Edward K. Geissler

    منشور في 2020
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: